Transformation of pituitary and fibroblast cell lines using human insulin c-DNA and a dexamethasone-inducible promoter.
Simpson
A M
AM
Department of Endocrinology, Prince of Wales Hospital, New South Wales, Australia.
Iland
H
H
Clarke
R A
RA
Burn
A L
AL
Tuch
B E
BE
D015124:8-Bromo Cyclic Adenosine Monophosphate / Q000494:pharmacology; D002460:Cell Line; D018076:DNA, Complementary / Q000235:genetics*; D003907:Dexamethasone / Q000494:pharmacology; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D005818:Genetic Engineering; D006801:Humans; D007328:Insulin / Q000235:genetics* / Q000378:metabolism*; D007332:Insulin Infusion Systems; D000078790:Insulin Secretion; D010902:Pituitary Gland / Q000187:drug effects / Q000378:metabolism; D011401:Promoter Regions, Genetic / Q000187:drug effects; D014170:Transformation, Genetic
D018076:DNA, Complementary; D007328:Insulin; D015124:8-Bromo Cyclic Adenosine Monophosphate; D003907:Dexamethasone